UPDATE: Stifel Downgrades Synta Pharmaceuticals as GALAXY-2 Adjustments Further Diminish Likelihood For Success
March 12, 2014 at 08:13 AM EDT
In a report published Wednesday, Stifel analyst Brian Klein downgraded the rating on Synta Pharmaceuticals (NASDAQ: SNTA) from Hold to ...
